COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

Clinical trial NCT07281027 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07281027
Sponsor: Yale University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

New Onset Refractory Status Epilepticus New-Onset Refractory Status Epilepticus Febrile Infection-Related Epilepsy Syndrome (FIRES)

Start date: 2026-07-01
Primary completion: 2030-03-31
Enrollment: 438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.